Topic Hub
5 clinically reviewed articles, written and peer-reviewed by the WomanRx.com Medical Team.
Explore
Showing 5 of 5 clinical reviews.
Wegovy (semaglutide 2.4 mg) is being studied off-label for alcohol use disorder. Here is what the current data shows for women, including risks, benefits, and pregnancy safety.
Read clinical reviewCan Wegovy (semaglutide 2.4 mg) treat binge eating disorder off-label? A clinician-reviewed summary of the trial data, women-specific risks, and what to ask your provider.
Read clinical reviewWegovy (semaglutide 2.4 mg) is used off-label for binge eating disorder. Learn what the evidence shows, how dosing works, and what matters most for women.
Read clinical reviewWegovy (semaglutide 2.4 mg) is used off-label for binge eating disorder in women. Learn the evidence, monitoring requirements, and what differs by life stage.
Read clinical reviewWegovy (semaglutide 2.4 mg) is being used off-label for NASH. Here's what the clinical evidence shows, what it means for women, and who may benefit.
Read clinical review